BioXcel Therapeutics, Inc.
BTAIQ- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720893
No open-market purchases or sales by BioXcel Therapeutics, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $8.69M in total; Oaktree Capital is the only superinvestor holding it.
13F holders, Q2 2026
Institutional positions in BioXcel Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +7 vs. Q1 2026
- Shares held
- 6.18M
- +734.8K (+13.5%) vs. Q1 2026
- Total value
- $8.69M
- +$1.41M (+19.4%) vs. Q1 2026
- New holders
- 10
- 12 more added
- Sold out
- 3
- 8 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BTAIQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 47 | $8.69M |
| Q1 2026 | 40 | $7.28M |
| Q4 2025 | 41 | $5.66M |
| Q3 2025 | 35 | $6.05M |
| Q2 2025 | 35 | $1.19M |
| Q1 2025 | 31 | $769.7K |
| Q4 2024 | 49 | $3.22M |
| Q3 2024 | 50 | $1.89M |
| Q2 2024 | 74 | $12.5M |
| Q1 2024 | 74 | $27.3M |
| Q4 2023 | 73 | $28.2M |
| Q3 2023 | 86 | $25.8M |
| Q2 2023 | 88 | $117.8M |
| Q1 2023 | 97 | $404.8M |
| Q4 2022 | 84 | $288.9M |
| Q3 2022 | 85 | $140.3M |
| Q2 2022 | 94 | $167.4M |
| Q1 2022 | 96 | $273.9M |
| Q4 2021 | 93 | $287.1M |
| Q3 2021 | 104 | $388.3M |
| Q2 2021 | 109 | $378.6M |
| Q1 2021 | 118 | $475.2M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding BioXcel Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Millennium Management LLC | 2,114,710 | $2.98M | 0.00% | +177,950+9.2% | Added |
| Oaktree Capital Management LPSuperinvestorOaktree Capital | 1,380,248 | $1.95M | 0.04% | +1,139,060+472.3% | Added |
| Vanguard Capital Management LLC | 919,545 | $1.30M | 0.00% | +712,206+343.5% | Added |
| Oaktree Fund Advisors, LLC | 245,585 | $346.3K | 0.60% | +202,672+472.3% | Added |
| Geode Capital Management, LLC | 242,251 | $341.9K | 0.00% | +12,083+5.2% | Added |
| BlackRock, Inc. | 179,433 | $253.0K | 0.00% | +95,151+112.9% | Added |
| UBS Group AG | 158,065 | $222.9K | 0.00% | +105,277+199.4% | Added |
| Citadel Advisors LLC | 149,220 | $210.4K | 0.00% | +149,220 | New |
| Vanguard Fiduciary Trust Co | 136,937 | $193.1K | 0.00% | +52,016+61.3% | Added |
| State Street Corp | 92,118 | $129.9K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 90,300 | $127.3K | 0.00% | 00.0% | Unchanged |
| Wiley Bros.-Aintree Capital, LLC | 83,588 | $117.9K | 0.00% | +2,724+3.4% | Added |
| Jones Financial Companies LLLP | 63,139 | $82.7K | 0.00% | −68,650−52.1% | Reduced |
| Northern Trust Corp | 56,318 | $79.4K | 0.00% | +20,005+55.1% | Added |
| HighTower Advisors, LLC | 41,000 | $57.8K | 0.00% | 00.0% | Unchanged |
| Quadrature Capital Ltd | 38,038 | $53.6K | 0.00% | +38,038 | New |
| Headlands Technologies LLC | 25,556 | $36.0K | 0.00% | +25,556 | New |
| StoneX Group Inc. | 20,684 | $29.2K | 0.00% | +20,684 | New |
| Beacon Pointe Advisors, LLC | 18,837 | $26.6K | 0.00% | −40−0.2% | Reduced |
| Susquehanna International Group, LLP | 17,200 | $24.3K | 0.00% | +17,200 | New |
| Portfolio Strategies, Inc. | 16,831 | $23.7K | 0.00% | +4,653+38.2% | Added |
| Virtu Financial LLC | 15,967 | $23.0K | 0.00% | +15,967 | New |
| Advisor Group Holdings, Inc. | 16,214 | $22.9K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 10,796 | $15.2K | 0.00% | +10,796 | New |
| Diversify Wealth Management, LLC | 15,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| Diversify Advisory Services, LLC | 15,000 | $13.0K | 0.00% | +15,000 | New |
| Wells Fargo & Company | 4,337 | $6.12K | 0.00% | +18+0.4% | Added |
| Citigroup Inc | 2,998 | $4.23K | 0.00% | +2,998 | New |
| Morgan Stanley | 1,671 | $2.36K | 0.00% | −8,917−84.2% | Reduced |
| Barclays PLC | 1,428 | $2.01K | 0.00% | +1,428 | New |
| GWM Advisors LLC | 1,331 | $1.88K | 0.00% | 00.0% | Unchanged |
| Vanguard Global Advisers, LLC | 493 | $695 | 0.00% | 00.0% | Unchanged |
| Silver Grove Financial Group, Inc. | 331 | $468 | 0.00% | −3−0.9% | Reduced |
| Tower Research Capital LLC (TRC) | 227 | $320 | 0.00% | −1,491−86.8% | Reduced |
| Parkside Financial Bank & Trust | 112 | $158 | 0.00% | 00.0% | Unchanged |
| Washington Trust Advisors, Inc. | 82 | $116 | 0.00% | −78−48.8% | Reduced |
| EverSource Wealth Advisors, LLC | 60 | $85 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 45 | $63 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 25 | $35 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 21 | $30 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 13 | $18 | 0.00% | −1−7.1% | Reduced |
| IFP Advisors, Inc | 13 | $18 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 12 | $17 | 0.00% | −47−79.7% | Reduced |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2 | $3 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Triumph Capital Management | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −1,910,076−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −96,473−100.0% | Sold out |
| Annis Gardner Whiting Capital Advisors, LLC | 0 | $0 | 0.00% | −156−100.0% | Sold out |